GoodRx Holdings (GDRX) Intangibles (2019 - 2026)

GoodRx Holdings has disclosed Intangibles across 8 years of filings, most recently posting $140.3 million for Q2 2026.

• In Q2 2026, Intangibles rose 1.46% year-over-year to $140.3 million; the TTM figure through Jun 2026 stood at $140.3 million (up 1.46% YoY), while the FY2025 annual figure was $139.3 million, up 11.6% from the prior year.
• Intangibles came in at $140.3 million for Q2 2026 at GoodRx Holdings, roughly flat from $140.2 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $142.1 million in Q3 2025 to a low of $86.0 million in Q1 2022.
• Average Intangibles over 5 years is $120.3 million, with a median of $122.3 million recorded in 2024.
• Year-over-year, Intangibles surged 149.66% in 2022 and slipped 26.94% in 2023.
• Over 5 years, Intangibles stood at $119.9 million in 2022, then retreated by 20.38% to $95.4 million in 2023, then jumped by 30.74% to $124.8 million in 2024, then advanced by 11.6% to $139.3 million in 2025, then climbed by 0.75% to $140.3 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $140.3 million in Q2 2026, $140.2 million in Q1 2026, and $139.3 million in Q4 2025.